New application of sodium ferrous chlorophyll to promotion of erythropoiesis
A kind of technology of sodium iron chlorophyllin and erythropoietin, which is applied in the field of medicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0011] Example 1: Application of sodium iron chlorophyllin in the treatment of renal anemia caused by renal failure
[0012] Renal anemia is one of the important complications of chronic renal failure. Patients with renal failure are often accompanied by iron deficiency during hemodialysis. The conventional treatment is mainly injection of erythropoietin (EPO), supplemented by iron supplementation. Studies have shown that silkworm excrement Shengxuening Tablets (the main active ingredient is sodium iron chlorophyllin) can efficiently supplement biological iron, can promote the absorption of free iron in the body and food, and can also stimulate bone marrow cell proliferation. The purpose of this study is to compare the effect of Shengxuening Tablets and Ferrous Succinate Tablets combined with EPO in the treatment of renal anemia in maintenance hemodialysis patients with iron deficiency, and to observe the replacement effect of iron sodium chlorophyllin on EPO.
[0013] 1. Rese...
Embodiment 2
[0041] Example 2: Application of sodium iron chlorophyllin in the treatment of renal anemia in patients with chronic kidney disease stage 3-4
[0042] Renal anemia is one of the important complications of chronic kidney disease (CKD). Renal anemia in patients with CKD stage 3-4 is often accompanied by iron deficiency. The conventional treatment is mainly to inject erythropoietin (EPO) to supplement iron. The purpose of this study is to compare iron sodium chlorophyllin and ferrous succinate tablets, and if necessary, combine them with EPO to treat renal anemia in patients with CKD stage 3-4, and observe the substitution effect of iron sodium chlorophyllin on EPO.
[0043] 1. Research Methods
[0044] 1. Case selection This study was completed collaboratively by seven hospitals in Shanghai. Patients with CKD stage 3-4 renal anemia [eGFR 15-59ml / (min·1.73m 2 ), GFR=186×serum creatinine-1.154×age-0.203×0.742 (female)×1.233 (Chinese)], were randomly divided into test group (Shen...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com